193 related articles for article (PubMed ID: 23067031)
1. Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study.
Saragoussi D; Chollet J; Bineau S; Chalem Y; Milea D
Int J Clin Pract; 2012 Nov; 66(11):1079-87. PubMed ID: 23067031
[TBL] [Abstract][Full Text] [Related]
2. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
Khandker RK; Kruzikas DT; McLaughlin TP
J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
[TBL] [Abstract][Full Text] [Related]
3. [Antidepressants consumption in the global population in France].
Olié JP; Elomari F; Spadone C; Lépine JP
Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
[TBL] [Abstract][Full Text] [Related]
4. Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant.
Katz AJ; Dusetzina SB; Farley JF; Ellis AR; Gaynes BN; Castillo WC; Stürmer T; Hansen RA
Pharmacotherapy; 2012 Mar; 32(3):234-43. PubMed ID: 22392456
[TBL] [Abstract][Full Text] [Related]
5. Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial.
Nakajima S; Uchida H; Suzuki T; Watanabe K; Hirano J; Yagihashi T; Takeuchi H; Abe T; Kashima H; Mimura M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1983-9. PubMed ID: 21889560
[TBL] [Abstract][Full Text] [Related]
6. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
Leelahanaj T
J Med Assoc Thai; 2012 May; 95 Suppl 5():S29-37. PubMed ID: 22934442
[TBL] [Abstract][Full Text] [Related]
7. The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting.
Rathe JØ
Dan Med J; 2015 Oct; 62(10):B5148. PubMed ID: 26441397
[TBL] [Abstract][Full Text] [Related]
8. [Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients].
Lang JP; Meyer N; Doffoel M
Encephale; 2003; 29(4 Pt 1):362-5. PubMed ID: 14615706
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
[TBL] [Abstract][Full Text] [Related]
10. Switching antidepressant class does not improve response or remission in treatment-resistant depression.
Souery D; Serretti A; Calati R; Oswald P; Massat I; Konstantinidis A; Linotte S; Bollen J; Demyttenaere K; Kasper S; Lecrubier Y; Montgomery S; Zohar J; Mendlewicz J
J Clin Psychopharmacol; 2011 Aug; 31(4):512-6. PubMed ID: 21694617
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant switching among adherent patients treated for depression.
Marcus SC; Hassan M; Olfson M
Psychiatr Serv; 2009 May; 60(5):617-23. PubMed ID: 19411348
[TBL] [Abstract][Full Text] [Related]
12. Costs associated with changes in antidepressant treatment in a managed care population with major depressive disorder.
Schultz J; Joish V
Psychiatr Serv; 2009 Dec; 60(12):1604-11. PubMed ID: 19952150
[TBL] [Abstract][Full Text] [Related]
13. Persistence of antidepressant treatment for depressive disorder in Taiwan.
Wu CS; Shau WY; Chan HY; Lai MS
Gen Hosp Psychiatry; 2013; 35(3):279-85. PubMed ID: 23415578
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
15. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, correlates, and disease patterns of antidepressant use in Taiwan.
Kuo CC; Chien IC; Lin CH; Lee WG; Chou YJ; Lee CH; Chou P
Compr Psychiatry; 2011; 52(6):662-9. PubMed ID: 21353216
[TBL] [Abstract][Full Text] [Related]
17. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
[TBL] [Abstract][Full Text] [Related]
18. Prescription patterns of antidepressants: findings from a US claims database.
Milea D; Verpillat P; Guelfucci F; Toumi M; Lamure M
Curr Med Res Opin; 2010 Jun; 26(6):1343-53. PubMed ID: 20373875
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
Boulton DW; Balch AH; Royzman K; Patel CG; Berman RM; Mallikaarjun S; Reeves RA
J Psychopharmacol; 2010 Apr; 24(4):537-46. PubMed ID: 18832427
[TBL] [Abstract][Full Text] [Related]
20. Depression diagnoses and antidepressant use in primary care practices: a study from the Practice Partner Research Network (PPRNet).
Ornstein S; Stuart G; Jenkins R
J Fam Pract; 2000 Jan; 49(1):68-72. PubMed ID: 10678342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
